On July 1, 2021 Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (OTC: LACQ, LACQW) reported that, in connection with the closing of its previously announced merger with Leisure Acquisition Corp. ("LACQ"), the combined company, Ensysce Biosciences, Inc., will commence trading its common stock and warrants under the ticker symbols "LACQ" and "LACQW," respectively, on the OTC Market on July 1, 2021 (Press release, Ensysce Biosciences, JUL 1, 2021, View Source [SID1234585503]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

As previously announced, the merger was approved by LACQ’s shareholders on June 28, 2021 and closed on June 30, 2021. The Company will announce further trading information at a later time.